Holen Sie sich die Stockscreener-App
20.65
1.52%
0.31
Handel nachbörslich:
20.65
Tourmaline Bio Inc Aktie (TRML) Neueste Nachrichten
Fmr LLC Has $387,000 Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Graves Ophthalmopathy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts - EIN News
Wellington Management Group LLP Raises Stake in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat
The Manufacturers Life Insurance Company Buys 5,945 Shares of Orchid Island Capital, Inc. (NYSE:ORC) - Defense World
The Manufacturers Life Insurance Company Takes $226,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Holdings Lifted by Charles Schwab Investment Management Inc. - Defense World
Northrim BanCorp, Inc. (NASDAQ:NRIM) Shares Sold by BNP Paribas Financial Markets - Defense World
BNP Paribas Financial Markets Sells 1,132 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
BNP Paribas Financial Markets Sells 509 Shares of First Internet Bancorp (NASDAQ:INBK) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 74,430 Shares of The GEO Group, Inc. (NYSE:GEO) - Defense World
FY2025 EPS Estimates for Tourmaline Bio Increased by Analyst - Defense World
Analysts Issue Forecasts for Tourmaline Bio FY2025 Earnings - MarketBeat
Tourmaline Bio (NASDAQ:TRML) Earns Buy Rating from HC Wainwright - Defense World
Tourmaline Bio's (TRML) Buy Rating Reiterated at HC Wainwright - MarketBeat
Tourmaline Bio expands trial and advisory board By Investing.com - Investing.com South Africa
Tourmaline Bio Updates on Clinical Progress and Outlook - TipRanks
Tourmaline Bio Unveils Clinical Progress and New Indication - TipRanks
Tourmaline Bio expands trial and advisory board - Investing.com
Tourmaline Announces the Over-Enrollment of its Phase 2 TRANQUILITY Trial - Marketscreener.com
Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day - The Manila Times
Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates - EIN News
Tourmaline Bio's TRANQUILITY Trial Surpasses Enrollment Target, Expands into Aortic Aneurysm Treatment - StockTitan
Tourmaline Bio to host investor day - MSN
Critical Analysis: Burford Capital (NYSE:BUR) & MARA (NASDAQ:MARA) - Defense World
338,437 Shares in Tourmaline Bio, Inc. (NASDAQ:TRML) Bought by Point72 Asset Management L.P. - MarketBeat
BMO Capital Markets Begins Coverage on Tourmaline Bio (NASDAQ:TRML) - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $61.25 Consensus Target Price from Analysts - MarketBeat
Likelihood of Approval and Phase Transition Success Rate ModelPacibekitug in Atherosclerosis - GlobalData
Graves Ophthalmopathy Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR
Tourmaline Bio, Inc. (NASDAQ:TRML) is Acuta Capital Partners LLC's 3rd Largest Position - MarketBeat
Jennison Associates LLC Has $29.62 Million Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat
Prevent Blindness Declares Fifth Annual Thyroid Eye Disease Awareness Week as Nov. 18-24, 2024 - InvisionMag
This Week in Ophthalmology: Week of November 11, 2024 - Ophthalmology Times
Blue Owl Capital Holdings LP Adjusts Stake in Tourmaline Bio Inc - GuruFocus.com
HC Wainwright Reduces Earnings Estimates for Tourmaline Bio - Defense World
HC Wainwright Lowers Earnings Estimates for Tourmaline Bio - MarketBeat
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024 - The Manila Times
Midland Identifies Gold Potential on Its Caniapisc Au Project, James Bay - The Manila Times
Tourmaline Bio Sets Key Investor Day with Focus on Pacibekitug Development | TRML Stock News - StockTitan
Alternus Clean Energy Inc (NASDAQ:ALCE) Sees Significant Decrease in Short Interest - Defense World
Alchemy Investments Acquisition Corp 1 (NASDAQ:ALCY) Short Interest Update - Defense World
Short Interest in Alchemy Investments Acquisition Corp 1 (NASDAQ:ALCYW) Decreases By 97.6% - Defense World
TruBridge (NASDAQ:TBRG) Price Target Raised to $14.00 - Defense World
Greenlane Renewables (OTCMKTS:GRNWF) Trading 21.2% Higher – Here’s What Happened - Defense World
Global Healthcare & Medical Tourism News - Medical Tourism Magazine
Tourmaline Bio ATM - SVB Leerink
Varonis Systems, Inc. (NASDAQ:VRNS) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Tourmaline stock PT nudged by H.C. Wainwright, citing confidence in pacibekitug - Investing.com UK
Tourmaline Bio, Inc. Reports Third Quarter Financial Results - TipRanks
Tourmaline Bio (NASDAQ:TRML) Price Target Raised to $49.00 at HC Wainwright - MarketBeat
Tourmaline Bio Inc (TRML) Quarterly 10-Q Report - Quartzy
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Manila Times
Tourmaline Bio Reports Wider Q3 Loss, $314M Cash Runway Extends to 2027 | TRML Stock News - StockTitan
AlphaCentric Advisors LLC Sells 69,500 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat
Tourmaline Bio shares get buy rating on IL-6 study optimism - Investing.com Canada
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DICE, Q - GuruFocus.com
The Best Curling Irons, Based On Several Months Of Testing - Forbes
Tourmaline Bio to Present at Upcoming Investor Conferences - The Manila Times
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):